Estimate portfolio company execution beta

Estimate company sensitivity to an external portfolio execution factor using company regressions, random-effects heterogeneity, empirical-Bayes shrinkage, uncertainty intervals, and systematic variance shares.

What it's for

Separates portfolio-wide execution exposure from idiosyncratic movement so investors can see which companies amplify common shocks without overreading noisy raw correlations.

What you give it

Inputs split into evidence read from your connected systems, calibration your team owns, and numerical controls that affect precision but never the result's meaning.

Field Type Role Required
confidence_level number ≥ 0.5, ≤ 0.999 Your calibration Optional
material_beta_deviation number ≥ 0, ≤ 10 Your calibration Optional
max_detail_rows integer ≥ 1, ≤ 500 Numerical control Optional
minimum_periods_per_company integer ≥ 4, ≤ 10000 Your calibration Optional
observations array of objects (5 fields) ≥ 8 items Evidence Yes

Each observations record

Field Type Required
company_id string (non-empty) Yes
execution_return number Yes
id string (non-empty) Yes
period integer Yes
portfolio_execution_return number Yes
Example input
{
  "confidence_level": 0.9,
  "material_beta_deviation": 0.2,
  "minimum_periods_per_company": 8,
  "observations": [
    {
      "company_id": "company-a",
      "execution_return": -3.03,
      "id": "company-a:0",
      "period": 0,
      "portfolio_execution_return": -2
    },
    {
      "company_id": "company-a",
      "execution_return": -2.25,
      "id": "company-a:1",
      "period": 1,
      "portfolio_execution_return": -1.5
    },
    {
      "company_id": "company-a",
      "execution_return": -1.47,
      "id": "company-a:2",
      "period": 2,
      "portfolio_execution_return": -1
    },
    {
      "company_id": "company-a",
      "execution_return": -0.78,
      "id": "company-a:3",
      "period": 3,
      "portfolio_execution_return": -0.5
    },
    {
      "company_id": "company-a",
      "execution_return": 0.75,
      "id": "company-a:4",
      "period": 4,
      "portfolio_execution_return": 0.5
    },
    {
      "company_id": "company-a",
      "execution_return": 1.53,
      "id": "company-a:5",

Truncated for display — the full payload is 119 lines.

What you get back

This is the actual output of running the example above — computed by the same function the platform calls, not an illustration.

Example output
{
  "assumptions": [
    "The portfolio execution factor is externally defined, point-in-time, common within period, and excludes the focal company to avoid mechanical self-correlation; company and factor returns share cadence and units.",
    "Company relationships are approximately linear and stable over the selected epoch, residual dependence and serial correlation are limited, and at least the governed minimum periods span meaningful factor variation.",
    "Empirical-Bayes shrinkage and normal intervals quantify model-based association, not causality, investment quality, valuation, misconduct, or person performance; regime changes and common measurement error require separate tests."
  ],
  "company_diagnostics": [
    {
      "classification": "amplified_portfolio_exposure",
      "company_id": "company-a",
      "execution_beta_interval": [
        1.4905,
        1.5134
      ],
      "period_count": 8,
      "posterior_execution_beta": 1.5019,
      "raw_execution_beta": 1.502,
      "shrinkage_toward_portfolio_beta": 0.0001,
      "systematic_execution_variance_share": 0.9999
    },
    {
      "classification": "defensive_portfolio_exposure",
      "company_id": "company-b",
      "execution_beta_interval": [
        0.5906,
        0.6135
      ],
      "period_count": 8,
      "posterior_execution_beta": 0.6021,
      "raw_execution_beta": 0.602,
      "shrinkage_toward_portfolio_beta": -0.0001,
      "systematic_execution_variance_share": 0.9991
    }
  ],
  "configuration": {
    "confidence_level": 0.9,
    "material_beta_deviation": 0.2,
    "minimum_periods_per_company": 8
  },
  "decision": "portfolio_company_execution_beta_estimated",
  "method": "empirical_bayes_random_effects_execution_beta_v1",
  "summary": {
    "amplified_company_count": 1,
    "between_company_beta_variance": 0.405,

Truncated for display — the full payload is 51 lines.

How it works

Constrained optimization — Pick the best feasible option under real limits — budget, headcount, dependencies, capacity — rather than ranking a list and hoping it fits.

  1. 1 Freeze a point-in-time aggregate execution return, cadence and stable epoch for every company plus an external leave-one-company-out portfolio factor that is identical within period.
  2. 2 Fit company factor regressions, estimate sampling variance and cross-company random-effects heterogeneity, then shrink noisy raw betas toward the portfolio relationship with model-based intervals.
  3. 3 Classify only interval-supported amplified or defensive exposure relative to beta one, and report systematic variance share while keeping regime, serial/dependent error, and measurement audits separate.

Before you trust it

Every tool in the catalog ships with the conditions under which its answer is meaningful — and the conditions under which it should abstain instead of guessing.

Assumptions & guardrails

  • Objectives use commensurable locally governed value units, constraints reflect real feasibility, and uncertainty covers plausible adverse inputs.
  • The external factor excludes the focal company, rows share cadence and units, the relationship is locally linear and stable, factor variation is meaningful, and residual serial/cross-company dependence is limited or separately modeled.
  • The recommendation is optimal only for its stated objective, feasible set, evidence, and solver guarantee; it is not a universal management optimum.
  • Execution beta is an aggregate model-based association, not causality, valuation, investment quality, misconduct, employee performance, or evidence that management caused portfolio sensitivity.

Minimum evidence

  • observations: at least 8 rows/items

How to validate it

Backtest the chosen action against simple feasible baselines on held-out scenarios, sweep costs/constraints/risk tolerance, and require constraint feasibility under adverse inputs.

Calibrating it to your org

Same for everyone

The mathematical kernel, validation rules, method version, and JSON output semantics are organization-independent; no tenant-trained coefficients or company benchmark is embedded in the function.

Specific to you

  • external leave-one-company-out portfolio execution factor, stable-epoch company-period panel, and complete zero/quiet periods
  • investor access and aggregation boundary, execution-return definition, factor construction/exclusion, cadence/epoch, minimum periods, confidence, material beta deviation, missingness, regime policy, and disclosure rules

Calibration workflow

  1. 1 Define the management decision, target outcome, aggregate unit, privacy boundary, cadence, and prediction/intervention horizon for this organization.
  2. 2 Build a tenant-scoped historical cohort using only information available before each prediction or decision; preserve zero periods, censoring, assignment probabilities, and unresolved outcomes when the method requires them.
  3. 3 Estimate statistical parameters on training history, but obtain costs, utilities, risk tolerance, practical-effect thresholds, capacity, and policy constraints from accountable decision owners.
  4. 4 Validate on later time windows or held-out aggregate units at the deployment grain, against a simple baseline and the function-specific validation strategy.
  5. 5 Deploy only if the returned decision clears evidence, overlap, calibration, robustness, and guardrail checks; warning, unsupported, schema-gap, and fallback decisions are abstentions.
  6. 6 Monitor realized outcomes, data drift, coverage, and decision regret; recalibrate at a governed cadence or after a detected regime/definition change, never merely because a stakeholder dislikes the result.

Call it from your AI

You don't wire up 388 tools in your MCP client. The GitRevio MCP server exposes 18 tools, three of which let an agent search the catalog, read a tool's schema, and run it — so the assistant finds this one on its own.

gitrevio_capabilities_search
  { "q": "estimate company sensitivity to an external" }
  → finds "estimate_portfolio_company_execution_beta"

gitrevio_capability_describe
  { "capability_id": "estimate_portfolio_company_execution_beta" }
  → returns the input schema and agent guidance shown on this page

gitrevio_capability_run
  { "capability_id": "estimate_portfolio_company_execution_beta", "arguments": { ... } }
  → returns the result shown above

Works in Claude Desktop, Claude Code, Cursor, Cline, Continue.dev, Goose and Aider. See the MCP server.

Related tools

Rank portfolio companies by risk adjusted progress

Rank stage-comparable portfolio companies by evidence-shrunk milestone value minus a CVaR downside penalty per cash consumed, with weak evidence explicitly unranked.

Constrained optimization

Stress test investment memo assumptions

Stress an investment memo's local value model by shrinking weak claims toward declared adverse values, pricing pairwise nonlinear interactions, and finding the first failure fraction along a joint adverse path.

Decision analysis

Allocate budget with CVAR constraint

Maximize expected portfolio return while keeping probability-weighted loss CVaR below a finance-owned tail-risk ceiling across aligned joint scenarios.

Constrained optimization

Audit budget constraint binding

Audit whether a claimed budget constraint genuinely blocks value after dependency-feasible portfolio reallocation, separating current-plan inefficiency from scarcity with scenario CVaR and a discrete budget shadow price.

Constrained optimization

Audit financing term sheet integrity

Audit startup financing terms as exact share, price, proceeds and ownership identities: include pre-money option-pool increases and converting instruments in the pricing denominator, keep secondary purchases out of company cash and post-money share creation, reconcile primary issuance, post-money equity value and reported investor ownership, and retain evidence failures and impossible fees or secondary sales.

Statistical audit & measurement

Audit fundraising pipeline integrity

Audit a fundraising pipeline as point-in-time evidence rather than CRM theater: reconstruct monotone stage events, terminal status and primary proceeds, retain open opportunities as censored, reject forecasts made after resolution, detect duplicate active investor accounts, and gate the portfolio on mature-forecast support, Brier loss and calibration gap.

Forecasting & survival

See every tool in Investment & portfolio choice →

Ready to See Your Engineering work clearly?

Request a free demo